LiDCO is a supplier of non-invasive and minimally invasive hemodynamic equipment used to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. Clinical studies show that optimising the hemodynamic status of high risk patients produces better outcomes and reduced hospital stay. Since launching our first product in 1999, LiDCO has been committed to improving patient outcomes whilst providing excellent customer service. Dedicated to making a difference.
Proven to improve patient outcomes. Over 200 clinical studies.
We will work with you to implement our technology.
We go the extra mile to support our customers.
Core clinical algorithm unchanged for 15 years.
Extensively validated including when used with vasoactive drugs.
Hemodynamic monitoring across the whole clinical pathway with one disposable.
17 May 2018
LiDCO (AIM: LID), the hemodynamic monitoring company, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
For further information, please contact:
SCCM Critical Care Congress | San Antonio | 25-28 February 2018
Connect with colleagues, network and collaborate with critical care experts, and explore new tools, technologies and processes at the Society of Critical Care Medicine’s (SCCM) 47th Critical Care Congress
Responsible for providing clinical expertise, in-servicing, education and driving opportunities with the LiDCO hemodynamic monitoring product portfolio.
In accordance with our GDPR policy, any CV’s or other personal information…